Daily19 小时
Tralokinumab Promising for Moderate-to-Severe Atopic Dermatitis: 28-Week Real-World Study ...
Netherlands: A recent study demonstrated that tralokinumab is an effective treatment for moderate-to-severe atopic dermatitis ...